123 related articles for article (PubMed ID: 9160354)
1. Inhibition by galloylglucose (GG6-10) of tumor invasion through extracellular matrix and gelatinase-mediated degradation of type IV collagens by metastatic tumor cells.
Ata N; Oku T; Hattori M; Fujii H; Nakajima M; Saiki I
Oncol Res; 1996; 8(12):503-11. PubMed ID: 9160354
[TBL] [Abstract][Full Text] [Related]
2. MMP-9 from TNF alpha-stimulated keratinocytes binds to cell membranes and type I collagen: a cause for extended matrix degradation in inflammation?
Mäkelä M; Salo T; Larjava H
Biochem Biophys Res Commun; 1998 Dec; 253(2):325-35. PubMed ID: 9878537
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma.
Qin H; Moellinger JD; Wells A; Windsor LJ; Sun Y; Benveniste EN
J Immunol; 1998 Dec; 161(12):6664-73. PubMed ID: 9862695
[TBL] [Abstract][Full Text] [Related]
4. Suppression of tumor cell invasiveness by hydrolyzable tannins (plant polyphenols) via the inhibition of matrix metalloproteinase-2/-9 activity.
Tanimura S; Kadomoto R; Tanaka T; Zhang YJ; Kouno I; Kohno M
Biochem Biophys Res Commun; 2005 May; 330(4):1306-13. PubMed ID: 15823585
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone.
Elkin M; Reich R; Nagler A; Aingorn E; Pines M; de-Groot N; Hochberg A; Vlodavsky I
Clin Cancer Res; 1999 Aug; 5(8):1982-8. PubMed ID: 10473075
[TBL] [Abstract][Full Text] [Related]
6. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2.
Deryugina EI; Luo GX; Reisfeld RA; Bourdon MA; Strongin A
Anticancer Res; 1997; 17(5A):3201-10. PubMed ID: 9413149
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ
Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572
[TBL] [Abstract][Full Text] [Related]
8. Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes.
Parmo-Cabañas M; Molina-Ortiz I; Matías-Román S; García-Bernal D; Carvajal-Vergara X; Valle I; Pandiella A; Arroyo AG; Teixidó J
J Pathol; 2006 Jan; 208(1):108-18. PubMed ID: 16278822
[TBL] [Abstract][Full Text] [Related]
9. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.
Murata J; Ayukawa K; Ogasawara M; Fujii H; Saiki I
Invasion Metastasis; 1997; 17(2):82-93. PubMed ID: 9561027
[TBL] [Abstract][Full Text] [Related]
10. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane.
Xia M; Leppert D; Hauser SL; Sreedharan SP; Nelson PJ; Krensky AM; Goetzl EJ
J Immunol; 1996 Jan; 156(1):160-7. PubMed ID: 8598457
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid stimulates meningioma cell adhesion to the extracellular matrix and inhibits invasion.
Pereda MP; Hopfner U; Pagotto U; Renner U; Uhl E; Arzt E; Missale C; Stalla GK
Br J Cancer; 1999 Oct; 81(3):381-6. PubMed ID: 10507760
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-derived serine proteinases enhance membrane type-1 matrix metalloproteinase-dependent tumor cell invasion.
Shamamian P; Pocock BJ; Schwartz JD; Monea S; Chuang N; Whiting D; Marcus SG; Galloway AC; Mignatti P
Surgery; 2000 Feb; 127(2):142-7. PubMed ID: 10686978
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effects of matrix metalloproteinase (MMP) inhibitor LY52 on expression of MMP-2 and MMP-9 and invasive ability of human ovarian carcinoma cell line SKOV3].
Yuan YX; Xu WF; Liu J; Chen MH; Meng H; Qu XJ
Ai Zheng; 2006 Jun; 25(6):663-70. PubMed ID: 16764758
[TBL] [Abstract][Full Text] [Related]
14. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor.
Nabeshima K; Inoue T; Shimao Y; Okada Y; Itoh Y; Seiki M; Koono M
Cancer Res; 2000 Jul; 60(13):3364-9. PubMed ID: 10910039
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of membrane-type 1 matrix metalloproteinase at cell-matrix adhesions.
Takino T; Saeki H; Miyamori H; Kudo T; Sato H
Cancer Res; 2007 Dec; 67(24):11621-9. PubMed ID: 18089791
[TBL] [Abstract][Full Text] [Related]
16. Fibronectin-bound TNF-alpha stimulates monocyte matrix metalloproteinase-9 expression and regulates chemotaxis.
Vaday GG; Hershkoviz R; Rahat MA; Lahat N; Cahalon L; Lider O
J Leukoc Biol; 2000 Nov; 68(5):737-47. PubMed ID: 11073115
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of the inhibitory effect of epigallocatechin-3-gallate on cultured human vascular smooth muscle cell invasion.
Cheng XW; Kuzuya M; Nakamura K; Liu Z; Di Q; Hasegawa J; Iwata M; Murohara T; Yokota M; Iguchi A
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1864-70. PubMed ID: 16051878
[TBL] [Abstract][Full Text] [Related]
18. Tetrahydrocurcumin inhibits HT1080 cell migration and invasion via downregulation of MMPs and uPA.
Yodkeeree S; Garbisa S; Limtrakul P
Acta Pharmacol Sin; 2008 Jul; 29(7):853-60. PubMed ID: 18565284
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclines.
Gu Y; Lee HM; Golub LM; Sorsa T; Konttinen YT; Simon SR
Ann Med; 2005; 37(6):450-60. PubMed ID: 16203617
[TBL] [Abstract][Full Text] [Related]
20. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
